Recent and archived press releases with clinical and research news
The Phase 3 CELLEBRATE trial to test a regenerative stem cell-based therapy in treating patients with stress urinary incontinence is continuing to recruit additional subjects after changing its study protocol to include only patients who have already tried surgery.
Vanderbilt University School of Medicine, which received $527.7 million in direct and indirect NIH grant support in FY23, has been among the top 10 U.S. medical schools in NIH funding for six of the last 10 years.
At the HIMSS 2024 Global Health Conference, Vanderbilt University Medical Center (VUMC) and other leading academic medical centers joined as Microsoft announced the formation of a new consortium, the Trustworthy & Responsible AI Network (TRAIN).
A U.S.-Canadian research collaboration led by Vanderbilt University Medical Center has identified common, age-associated changes in the blood as a risk factor for acute kidney injury, which occurs in more than 1 in 5 hospitalized adults worldwide.
The Department of Biomedical Informatics at Vanderbilt University Medical Center has launched its groundbreaking center for health Artificial Intelligence (AI) – ADVANCE (AI Discovery and Vigilance to Accelerate Innovation and Clinical Excellence).
A new Vanderbilt University Medical Center clinical laboratory facility is open for business following a relocation to a 110,000 square-foot facility in MetroCenter. The new lab is located approximately five miles from VUMC’s main Nashville campus.